相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Structure of the factor VIII C2 domain in a ternary complex with 2 inhibitor antibodies reveals classical and nonclassical epitopes
Justin D. Walter et al.
BLOOD (2013)
Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition)
Peter W. Collins et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
The World Federation of Hemophilia guideline on management of haemophilia
M. Makris et al.
HAEMOPHILIA (2013)
Preclinical Models Used for Immunogenicity Prediction of Therapeutic Proteins
Vera Brinks et al.
PHARMACEUTICAL RESEARCH (2013)
The Reversal of Inhibitors in Congenital Hemophilia
Sean R. DeFrates et al.
PHARMACOTHERAPY (2013)
Acquired haemophilia A: A 2013 update
Massimo Franchini et al.
THROMBOSIS AND HAEMOSTASIS (2013)
Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)
Peter Collins et al.
BLOOD (2012)
Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry
Francesco Baudo et al.
BLOOD (2012)
Pharmacokinetics and safety of OBI-1, a recombinant B domain-deleted porcine factor VIII, in subjects with haemophilia A
C. L. Kempton et al.
HAEMOPHILIA (2012)
Mechanisms and monitoring of bypassing agent therapy
M. Hoffman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Acquired Inhibitors of Coagulation Factors: Part I-Acquired Hemophilia A
Antonio Coppola et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2012)
Management of acquired haemophilia A
P. W. Collins
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
International recommendations on the diagnosis and treatment of patients with acquired hemophilia A
Angela Huth-Kuehne et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A
P. W. Collins et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Preclinical animal models for hemophilia gene therapy: Predictive value and limitations
FEM Rawle et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2004)
Comparative immunogenicity of recombinant B domain-deleted porcine factor VII and Hyate:C in hemophilia A mice presensitized to human factor VIII
ET Parker et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Comparative thrombotic event incidence after infusion of recombinant factor VIIa versus factor VII inhibitor bypass activity
LM Aledort
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Reduction of the inhibitory antibody response to human factor VIII in hemophilia A mice by mutagenesis of the A2 domain B-cell epitope
ET Parker et al.
BLOOD (2004)
Bioengineering of coagulation factor VIR for improved secretion
HZ Miao et al.
BLOOD (2004)
High level expression of recombinant porcine coagulation factor VIII
CB Doering et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Porcine factor VIII in the treatment of high-titre inhibitor patients
MB Garvey
HAEMOPHILIA (2002)
Detection and characterization of porcine endogenous retrovirus in porcine plasma and porcine factor VIII
DM Takefman et al.
JOURNAL OF VIROLOGY (2001)
分享论文
